ZBH Zimmer Biomet Holdings Inc

Price (delayed)

$159.97

Market cap

$33.35B

P/E Ratio

58.38

Dividend/share

$0.96

EPS

$2.74

Enterprise value

$40.47B

Zimmer Biomet is a publicly traded medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of ...

Highlights
The net income has surged by 51% year-on-year
The EPS has grown by 48% YoY
Zimmer Biomet Holdings's gross profit has decreased by 12% YoY
The revenue has contracted by 9% YoY

Key stats

What are the main financial stats of ZBH
Market
Shares outstanding
208.48M
Market cap
$33.35B
Enterprise value
$40.47B
Valuations
Price to earnings (P/E)
58.38
Price to book (P/B)
2.67
Price to sales (P/S)
4.69
EV/EBIT
61.14
EV/EBITDA
23.66
EV/Sales
5.71
Earnings
Revenue
$7.09B
EBIT
$661.8M
EBITDA
$1.71B
Free cash flow
$606.4M
Per share
EPS
$2.74
Free cash flow per share
$2.92
Book value per share
$59.87
Revenue per share
$34.08
TBVPS
$38.42
Balance sheet
Total assets
$24.03B
Total liabilities
$11.58B
Debt
$7.84B
Equity
$12.45B
Working capital
$2.91B
Liquidity
Debt to equity
0.63
Current ratio
2.39
Quick ratio
1.01
Net debt/EBITDA
4.16
Margins
EBITDA margin
24.1%
Gross margin
69.6%
Net margin
8%
Operating margin
8.9%
Efficiency
Return on assets
2.4%
Return on equity
4.7%
Return on invested capital
5.1%
Return on capital employed
3%
Return on sales
9.3%
Dividend
Dividend yield
0.6%
DPS
$0.96
Payout ratio
35%

ZBH stock price

How has the Zimmer Biomet Holdings stock price performed over time
Intraday
0.83%
1 week
4.28%
1 month
-2.74%
1 year
20.49%
YTD
3.82%
QTD
-0.53%

Financial performance

How have Zimmer Biomet Holdings's revenue and profit performed over time
Revenue
$7.09B
Gross profit
$4.93B
Operating income
$633.8M
Net income
$567.7M
Gross margin
69.6%
Net margin
8%
Zimmer Biomet Holdings's operating margin has surged by 107% YoY
Zimmer Biomet Holdings's operating income has surged by 91% YoY
The net margin has surged by 67% year-on-year
The net income has surged by 51% year-on-year

Growth

What is Zimmer Biomet Holdings's growth rate over time

Valuation

What is Zimmer Biomet Holdings stock price valuation
P/E
58.38
P/B
2.67
P/S
4.69
EV/EBIT
61.14
EV/EBITDA
23.66
EV/Sales
5.71
The EPS has grown by 48% YoY
The stock's P/B is 21% above its 5-year quarterly average of 2.2 and 11% above its last 4 quarters average of 2.4
ZBH's equity is up by 4.8% year-on-year and by 2.1% since the previous quarter
ZBH's price to sales (P/S) is 38% higher than its 5-year quarterly average of 3.4 and 12% higher than its last 4 quarters average of 4.2
The revenue has contracted by 9% YoY

Efficiency

How efficient is Zimmer Biomet Holdings business performance
The ROS has soared by 121% YoY
The ROIC has soared by 82% YoY
The ROA has soared by 60% YoY
Zimmer Biomet Holdings's return on equity has surged by 52% YoY

Dividends

What is ZBH's dividend history
DPS
$0.96
Dividend yield
0.6%
Payout ratio
35%
Recent dividends

Financial health

How did Zimmer Biomet Holdings financials performed over time
The total assets is 108% higher than the total liabilities
The current ratio has grown by 41% YoY and by 20% from the previous quarter
Zimmer Biomet Holdings's total liabilities has decreased by 15% YoY and by 5% QoQ
The debt is 37% smaller than the equity
The debt to equity has declined by 22% year-on-year and by 6% since the previous quarter
The debt has declined by 19% year-on-year and by 3.5% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.